# Shanghai Xuanyu Medical Equipment Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-xuanyu-medical-equipment-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.shineyomedical.com
- Total disclosed funding: $29M
- Latest round: Series A (Apr 2, 2025)
- Investors on record: 12

## About

Founded in 2020 and based in Shanghai, China, Shanghai Xuanyu Medical Equipment Co., Ltd. is a medical equipment company that focuses on the research and development of electrophysiology and peripheral vascular minimally invasive interventional devices. In 2022, the company's multichannel pulsed electric field ablation instrument completed the first clinical trial. The company has acquired Shanghai High-Tech Enterprise Certification and Shanghai Specialized, Refined, Featured and Original SME. Its core product, the RHYTHPULSE® multi-channel pulsed field ablation (PFA) system, was officially approved for marketing by NMPA on February 26, 2025. In April 2025, it closed a series A++ and series A+++ funding.

The company's products include the Rhythpulse® multichannel cardiac pulsed electric field ablation system and the VariSeal® vein closure system, which can be used to treat atrial fibrillation, varicose veins and other diseases.

Shanghai Xuanyu Medical Equipment Co., Ltd. generates revenues by manufacturing and selling electrophysiological and peripheral vascular minimally invasive interventional devices.

The company will use series A++ and A+++ funding to build marketing networks, expand industrialization bases and lay out innovative R&D pipelines.

## Funding rounds

- Series A, Apr 2, 2025 — Efung Capital
- Series A, Apr 2, 2025 — Guangzhou Baiyun Financial Holding Group
- Series A, Jul 3, 2024, $14M — Jinkong Fund Management, Zhangjiagang Industrial Capital Center, Suzhou Zhuopu Fund Management, Jinxin Capital
- Series A, Jun 21, 2022, $15M — BMC, Dalton Venture, Apricot Capital, HiMed Angle Fund Management, Industrial Securities Capital
- Angel, Feb 26, 2021 — BMC, Tianjin Gaorui Jingyan Information Consulting Service

## Investors

- BMC (https://capitalatlas.ai/funds/bmc) — Angel, Series A
- Tianjin Gaorui Jingyan Information Consulting Service — Angel
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A
- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A
- HiMed Angle Fund Management (https://capitalatlas.ai/funds/himed-angle-fund-management) — Series A
- Industrial Securities Capital — Series A
- Jinkong Fund Management (https://capitalatlas.ai/funds/jinkong-fund-management) — Series A
- Zhangjiagang Industrial Capital Center (https://capitalatlas.ai/funds/zhangjiagang-industrial-capital-center) — Series A
- Suzhou Zhuopu Fund Management — Series A
- Jinxin Capital — Series A
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series A
- Guangzhou Baiyun Financial Holding Group (https://capitalatlas.ai/funds/guangzhou-baiyun-financial-holding-group) — Series A